Clinical-stage precision oncology company using computational biology to develop therapies that shut down the RAS/MAPK pathway.
Pricing
Custom pricing
Founded
2018
Team size
51-200 employees
About Erasca
Clinical-stage precision oncology company using computational biology to develop therapies that shut down the RAS/MAPK pathway.